Cycurion, Inc. Warrant financials
$0.0161−50.00%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 |
|---|---|---|---|---|---|---|
| Revenue | $3.8M | $3.3M | $3.5M | $3.8M | $3.9M | $3.9M |
| Gross profit | $1.1M | $688.4K | $428.1K | $270.5K | $235.9K | $677.8K |
| Gross margin | 29.1% | 21.1% | 12.1% | 7.1% | 6.1% | 17.5% |
| Operating income | -$1.9M | -$2.4M | -$5.0M | -$4.5M | -$3.8M | -$10.1M |
| Net income | -$3.8M | -$2.1M | -$5.1M | -$3.1M | -$5.2M | -$10.2M |
| Net margin | −100.0% | −65.1% | −144.1% | −81.5% | −133.5% | −264.8% |
| Diluted EPS | $-3.28 | $-3.76 | $-18.82 | $-12.50 | $-27.04 | $-59.20 |
| EBITDA | -$1.9M | -$2.4M | -$4.4M | -$4.5M | -$3.1M | $350.4K |
| Operating cash flow | -$3.3M | -$2.9M | -$3.3M | -$2.5M | -$3.6M | -$2.7M |
| Free cash flow | -$3.4M | -$3.0M | -$3.5M | -$2.6M | -$3.6M | -$2.8M |
| Diluted shares | 1.1M | 0.6M | 0.3M | 0.3M | 0.2M | 0.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.9M | $2.0M | $5.3M | $3.7M | $1.0M | $2.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $8.9M | $9.4M | $9.5M | $8.1M | $10.0M | $10.9M |
| Total assets | $38.4M | $31.4M | $33.5M | $32.3M | $30.7M | $31.5M |
| Total liabilities | $20.2M | $17.8M | $17.2M | $16.9M | $20.3M | $22.1M |
| Shareholders' equity | $18.2M | $13.7M | $16.2M | $15.4M | $10.4M | $9.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology